TTK Healthcare Ltd
Mon 4/05/2026,14:19:55 | NSE : TTKHLTCARE
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 910.95
Previous Close
₹ 904.10
Volume
2094
Mkt Cap ( Rs. Cr)
₹1307.06
High
₹ 938.00
Low
₹ 909.20
52 Week High
₹ 1398.90
52 Week Low
₹ 735.00
Book Value Per Share
₹ 775.36
Dividend Yield
1.10
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on TTK Healthcare Ltd
Your Vote -
Buy
68.18%
Hold
0.00%
Sell
31.82%
68.18%
22 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
62%
Sell Order Quantity
38%
Bid Price
Qty
926.85
2
927.00
7
926.00
1
925.00
2
925.00
25
Bid Total
4569
Bid Price
Qty
929.95
2
930.00
46
930.00
3
931.00
3
931.00
7
Bid Total
2778
Option Chain
Analyzes market sentiment, predicts TTK Healthcare Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
TTK Healthcare - Disclosure under SEBI Takeover Regulations
-
TTK Healthcare - Copy of Newspaper Publication
-
TTK Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
TTK Healthcare - Disclosure under SEBI Takeover Regulations
-
TTK Healthcare - Disclosure under SEBI Takeover Regulations
-
TTK Healthcare - Disclosure under SEBI Takeover Regulations
-
TTK Healthcare - Disclosure under SEBI Takeover Regulations
-
TTK Healthcare - Disclosure under SEBI Takeover Regulations
-
TTK Healthcare - Disclosure under SEBI Takeover Regulations
-
TTK Healthcare - Disclosure under SEBI Takeover Regulations
-
TTK Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
TTK Healthcare - Disclosure under SEBI Takeover Regulations
-
TTK Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
TTK Healthcare - Trading Window
-
TTK Healthcare - Copy of Newspaper Publication
Key fundamentals
Evaluate the intrinsic value of TTK Healthcare Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 1086.9833 | 1022.3919 | 978.9124 | 350.0158 | 312.2446 |
| Liabilities | 1086.9833 | 1022.3919 | 978.9124 | 350.0158 | 312.2446 |
| Equity | 14.1303 | 14.1303 | 14.1303 | 14.1303 | 14.1303 |
| Gross Profit | 34.8282 | 37.3274 | 31.3492 | 21.8373 | 19.3195 |
| Net Profit | 81.6569 | 62.8419 | 639.7129 | 41.5883 | 46.4411 |
| Cash From Operating Activities | -3.9757 | -4.9433 | -26.0762 | 44.9963 | 96.4211 |
| NPM(%) | 10.18 | 8.34 | 88.22 | 6.94 | 9.75 |
| Revenue | 801.4934 | 752.7938 | 725.1103 | 599.2399 | 476.0586 |
| Expenses | 766.6652 | 715.4664 | 693.7611 | 577.4026 | 456.7391 |
| ROE(%) | 7.45 | 5.73 | 58.38 | 3.79 | 4.23 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 18 Jul 2025 | 10 | 100 | 1.08 | 1286.1 |
| 16 Jul 2024 | 10 | 100 | 1.08 | 1476.95 |
| 18 Jul 2023 | 10 | 100 | 1.08 | 1267.55 |
| 26 Jul 2022 | 10 | 100 | 1.08 | 755.8 |
| 12 Aug 2021 | 6 | 60 | 1.08 | 644.95 |
| 03 Sep 2020 | 3 | 30 | 1.08 | 448.6 |
| 01 Aug 2019 | 5 | 50 | 1.08 | 661.4 |
| 02 Aug 2018 | 5 | 50 | 1.08 | 885.15 |
| 27 Jul 2017 | 5 | 50 | 1.08 | 774.85 |
| 28 Jul 2016 | 5 | 50 | 1.08 | 976.5 |
| 13 Aug 2014 | 4 | 40 | 1.08 | 625.65 |
| 16 Jul 2013 | 4 | 40 | 1.08 | 560.2 |
| 03 Aug 2012 | 4 | 40 | 1.08 | 350.65 |
| 15 Jul 2011 | 4 | 40 | 1.08 | 430.4 |
| 16 Jul 2010 | 3.5 | 35 | 1.08 | 349 |
| 0 | 25 | 1.08 | 30 | |
| 0 | 25 | 1.08 | 83.65 | |
| 0 | 25 | 1.08 | 28.5 | |
| 0 | 25 | 1.08 | 28.25 | |
| 0 | 25 | 1.08 | 20.45 |
Peers
Other companies within the same industry or sector that are comparable to TTK Healthcare Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 731.05 | 2.19 | 43.41 | 517.81 | 301.39 | 0.68 |
| Lotus Eye Hospital and Institute Ltd | 118.00 | -0.73 | 380.65 | 1886.85 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 7.35 | -3.42 | 0.00 | 11836.83 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 699.00 | 0.62 | 0.00 | 1779.34 | -363.15 | 0.00 |
Company Info
The Company was incorporated on 21st May, 1958. In 1962, manufacture of ethical products commenced based on foreign know-how. The company started with the manufacture of `Woodwords Gripe Water' in 1959. In 1974, a basic chemicals Division was started with the object of synthesising pharmaceutical intermediate & chemicals. In 1975, the Indian Medicine Division was established for manufacturing herbal products. In 1982 an Animal welfare division was set up for manufacture of formulations for veternary use. In 1985, company diversified into the manufacture of ready to cereal snack foods. The plant is located at Hosakote in Karnataka state and it is equipped to manufacture 10,000 metric tonnes per annum of cereal foods. The estimated cost of the project was Rs 363 lakhs. The merger of TTK chemicals Ltd with this company has been sanctioned by the High Courts of Madras and Andhra Pradesh with retrospective effect from 1st June, 1988. 1995 - TTK Pharma to make heart valves; tests successful. - TTK to market artificial heart valves. 1996 - TTK Pharma signs pact for European knowhow. - Chitra launches heart valve. 1998 - TTK Pharma launches Woodward's oral formula. - TTK Pharma launches diarrhoea formulation. 2001 - TTK Healthcare eyes buyers for Hyderabad bulk facility. - TTK Health signs MoU with Shri Chithra institute. - TTK pharma makes tilting-disc heart valve. 2002 - TTK Healthcare to allot shares to shareholders of TTK Medica. 2003 - High Court approves TTK Healthcare's Capital Restructuring Plan. - TTK Healthcare - VRS at the Company's Medical Devices Division. 2006 - Mr. R Srinivasan, a leading Management Consultant has joined the Board of the Company as "Independent Director". - The Board has recommended a Dividend of Rs 2/- per Equity Share of Rs 10/- each. 2007 - Board has recommended a Dividend of Rs 2.50 per Equity Share of Rs 10/- each, 2008 - Board has recommended a Dividend of Rs 3.00 per Equity Share of Rs 10/- each. 2009 - TTK Healthcare - Acquisition of Orthopaedic Implants Business / Undertaking. 2010 - TTK Healthcare - TTK Forays into Ortho Segment with American Collaboration. - TTK Healthcare - TTK Forays into Ortho Segment with American Collaboration. - Board has recommended a Dividend of Rs. 3.50 per Equity Share of Rs. 10/- each. 2011 - Board has recommended a Dividend of Rs. 4.00 per Equity Shares of Rs. 10/- each. 2012 - The Board has recommended a Dividend of Rs. 4.00 per Equity Share of Rs. 10/- each. - TTK Healthcare starts production at Pellet manufacturing line at Hosakote factory. 2013 - Board recommended a Dividend of Rs. 4/- per Equity Share of Rs.10/- each (40%). - Mr T T Raghunathan, in addition to his existing responsibility as Executive Vice Chairman of the Company has been appointed as the Managing Director. 2014 - Board recommended a Dividend of Rs 4/- per Equity Share of Rs. 10/- each (40%) 2016 -TTK Healthcare commences production from new plant in Rajasthan -TTK Healthcare begin producing medical devices. 2022-The Company has launched an online portal www.lovedepot.com for the sale of Pleasure products.
The Company was incorporated on 21st May, 1958. In 1962, manufacture of ethical products commenced based on foreign know-how. The company started with the manufacture of `Woodwords Gripe Water' in 1959. In 1974, a basic chemicals Division was started with the object of synthesising pharmaceutical intermediate & chemicals. In 1975, the Indian Medicine Division was established for manufacturing herbal products. In 1982 an Animal welfare division was set up for manufacture of formulations for veternary use. In 1985, company diversified into the manufacture of ready to cereal snack foods. The plant is located at Hosakote in Karnataka state and it is equipped to manufacture 10,000 metric tonnes per annum of cereal foods. The estimated cost of the project was Rs 363 lakhs. The merger of TTK chemicals Ltd with this company has been sanctioned by the High Courts of Madras and Andhra Pradesh with retrospective effect from 1st June, 1988. 1995 - TTK Pharma to make heart valves; tests successful. - TTK to market artificial heart valves. 1996 - TTK Pharma signs pact for European knowhow. - Chitra launches heart valve. 1998 - TTK Pharma launches Woodward's oral formula. - TTK Pharma launches diarrhoea formulation. 2001 - TTK Healthcare eyes buyers for Hyderabad bulk facility. - TTK Health signs MoU with Shri Chithra institute. - TTK pharma makes tilting-disc heart valve. 2002 - TTK Healthcare to allot shares to shareholders of TTK Medica. 2003 - High Court approves TTK Healthcare's Capital Restructuring Plan. - TTK Healthcare - VRS at the Company's Medical Devices Division. 2006 - Mr. R Srinivasan, a leading Management Consultant has joined the Board of the Company as "Independent Director". - The Board has recommended a Dividend of Rs 2/- per Equity Share of Rs 10/- each. 2007 - Board has recommended a Dividend of Rs 2.50 per Equity Share of Rs 10/- each, 2008 - Board has recommended a Dividend of Rs 3.00 per Equity Share of Rs 10/- each. 2009 - TTK Healthcare - Acquisition of Orthopaedic Implants Business / Undertaking. 2010 - TTK Healthcare - TTK Forays into Ortho Segment with American Collaboration. - TTK Healthcare - TTK Forays into Ortho Segment with American Collaboration. - Board has recommended a Dividend of Rs. 3.50 per Equity Share of Rs. 10/- each. 2011 - Board has recommended a Dividend of Rs. 4.00 per Equity Shares of Rs. 10/- each. 2012 - The Board has recommended a Dividend of Rs. 4.00 per Equity Share of Rs. 10/- each. - TTK Healthcare starts production at Pellet manufacturing line at Hosakote factory. 2013 - Board recommended a Dividend of Rs. 4/- per Equity Share of Rs.10/- each (40%). - Mr T T Raghunathan, in addition to his existing responsibility as Executive Vice Chairman of the Company has been appointed as the Managing Director. 2014 - Board recommended a Dividend of Rs 4/- per Equity Share of Rs. 10/- each (40%) 2016 -TTK Healthcare commences production from new plant in Rajasthan -TTK Healthcare begin producing medical devices. 2022-The Company has launched an online portal www.lovedepot.com for the sale of Pleasure products.
Read More
Parent Organisation
TTK Healthcare Ltd.
Founded
21/05/1958
Managing Director
Mr.S Kalyanaraman
NSE Symbol
TTKHLTCAREEQ
FAQ
The current price of TTK Healthcare Ltd is ₹ 925.00.
The 52-week high for TTK Healthcare Ltd is ₹ 938.00 and the 52-week low is ₹ 909.20.
The market capitalization of TTK Healthcare Ltd is currently ₹ 1307.06. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy TTK Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in TTK Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase TTK Healthcare Ltd shares.
The CEO of TTK Healthcare Ltd is Mr.S Kalyanaraman, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
